Summary

In patients with anterior ST segment elevation myocardial infarction who are treated by primary percutaneous coronary intervention (PCI), adjunct treatment with intracoronary (IC) eptifibatide did not improve the primary endpoint of post-PCI epicardial flow compared with IC tirofiban.